- Home
- PULM vs EQS Comparison
PULM vs EQS Comparison
Compare PULM & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- EQS
- Stock Information
- Founded
- PULM 2003
- EQS 1991
- Country
- PULM United States
- EQS United States
- Employees
- PULM N/A
- EQS N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- PULM Health Care
- EQS Finance
- Exchange
- PULM Nasdaq
- EQS Nasdaq
- Market Cap
- PULM 20.5M
- EQS 20.1M
- IPO Year
- PULM N/A
- EQS N/A
- Fundamental
- Price
- PULM $4.71
- EQS $1.87
- Analyst Decision
- PULM
- EQS
- Analyst Count
- PULM 0
- EQS 0
- Target Price
- PULM N/A
- EQS N/A
- AVG Volume (30 Days)
- PULM 10.4K
- EQS 61.7K
- Earning Date
- PULM 08-06-2025
- EQS 01-01-0001
- Dividend Yield
- PULM N/A
- EQS N/A
- EPS Growth
- PULM N/A
- EQS N/A
- EPS
- PULM N/A
- EQS N/A
- Revenue
- PULM $369,000.00
- EQS $1,355,000.00
- Revenue This Year
- PULM N/A
- EQS N/A
- Revenue Next Year
- PULM $134.88
- EQS N/A
- P/E Ratio
- PULM N/A
- EQS N/A
- Revenue Growth
- PULM N/A
- EQS 152.66
- 52 Week Low
- PULM $1.78
- EQS $0.74
- 52 Week High
- PULM $10.40
- EQS $2.11
- Technical
- Relative Strength Index (RSI)
- PULM 32.51
- EQS 86.69
- Support Level
- PULM $4.65
- EQS $1.75
- Resistance Level
- PULM $5.09
- EQS $1.83
- Average True Range (ATR)
- PULM 0.28
- EQS 0.13
- MACD
- PULM -0.01
- EQS 0.03
- Stochastic Oscillator
- PULM 5.38
- EQS 68.57
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.